Schakelaar Michael Y, Lentjes Eef G W M, Visser Timothy S Q, Schoneveld Arjan H, Hoefer Imo E, Tiel Groenestege Wouter M
Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.
Thyroid. 2023 Apr;33(4):449-455. doi: 10.1089/thy.2022.0453. Epub 2023 Mar 15.
Hyper- and hypothyroidism are prevalent in Western countries and often go unnoticed for long periods. Thyrotropin (TSH) as a biomarker of thyroid dysfunction is regularly measured in venous plasma/serum. In newborn screening for congenital hypothyroidism, TSH is measured from dried blood spots (DBSs). DBS enables minimally invasive (at-home) sampling of a small blood volume that can be sent to diagnostic laboratories by regular mail. In this study, we included 109 patients who presented to the outpatient clinic of the University Medical Center Utrecht. Capillary finger stick was used to spot blood on a filter paper card and was dried. After extraction of TSH from DBS, method comparison with venous TSH was performed on an automated high-throughput immunoassay analyzer. Additional validation steps regarding stability, effect of hematocrit (Hct), precision, and limits of blank and quantitation were conducted according to corresponding Clinical and Laboratory Standards Institute evaluation protocol. Method comparison of TSH from venous plasma versus finger stick DBSs showed an [95% confidence interval] = 0.988 [0.986-0.990]. This enabled correct diagnosis of hypothyrotropinemia and hypothyroidism in 12 of 14 and 6 of 7 cases, respectively, with no false positives. Furthermore, TSH from DBS was stable for at least 4 days at temperatures between -20°C and +30°C, and the maximum decrease of eluate TSH was 1.13% for 1% increase in Hct. TSH from DBS may be accurately measured on an automated high-throughput immunoassay analyzer and could be used to diagnose hypothyroidism and, for the first time, hypothyrotropinemia. This method, when confirmed in larger field studies, may enable individuals to engage in (at-home) sampling of blood on DBSs for telediagnostics, screening programs, patient follow-up, and medication management.
甲状腺功能亢进和减退在西方国家很常见,且常常长时间未被察觉。促甲状腺激素(TSH)作为甲状腺功能障碍的生物标志物,通常在静脉血浆/血清中进行测定。在先天性甲状腺功能减退症的新生儿筛查中,TSH是从干血斑(DBS)中进行测定的。DBS能够以微创(在家中)方式采集少量血液样本,并可通过普通邮件寄送至诊断实验室。在本研究中,我们纳入了109名到乌得勒支大学医学中心门诊就诊的患者。采用毛细血管手指采血法在滤纸片上采血并干燥。从DBS中提取TSH后,在自动高通量免疫分析分析仪上与静脉TSH进行方法比较。根据相应的临床和实验室标准协会评估方案,进行了关于稳定性、血细胞比容(Hct)的影响、精密度以及空白和定量限的额外验证步骤。静脉血浆TSH与手指采血DBS的TSH方法比较显示[95%置信区间]=0.988[0.986 - 0.990]。这分别在14例中的12例和7例中的6例中实现了对促甲状腺激素水平过低血症和甲状腺功能减退症的正确诊断,且无假阳性。此外,DBS中的TSH在-20°C至+30°C的温度下至少4天保持稳定,Hct每增加1%,洗脱液TSH的最大降幅为1.13%。DBS中的TSH可在自动高通量免疫分析分析仪上进行准确测量,并可用于诊断甲状腺功能减退症,且首次可用于诊断促甲状腺激素水平过低血症。该方法在更大规模的现场研究中得到证实后,可能使个人能够在家中对DBS进行血液采样,用于远程诊断、筛查项目、患者随访和药物管理。